PIN32 COST-UTILITY ANALYSIS OF NEW ANTIVIRAL TREATMENTS FOR NON-GENOTYPE 1 HEPATITIS C VIRUS IN CHINA: A SOCIETAL PERSPECTIVE
May 1, 2020, 00:00 AM
10.1016/j.jval.2020.04.505
https://www.valueinhealthjournal.com/article/S1098-3015(20)30693-8/fulltext
Section Title :
Section Order :
10386
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30693-8&doi=10.1016/j.jval.2020.04.505